Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

480.09
Delayed Data
As of Apr 24
 +0.01 / +0.00%
Today’s Change
269.50
Today|||52-Week Range
495.50
+17.02%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Operating ActivitiesNet Income / Starting Line65.4M92.7M79.7M110.2M
 
 
 
 
 
Depreciation11.5M13.0M14.0M14.1M
 
 
 
 
 
Total Other Cash Flow91.1M89.1M84.9M123.7M
 
 
 
 
 
Funds From Operations159.5M170.8M160.7M231.9M
 
 
 
 
 
Funds From/For Other Operating Expenses106.0M-157.0M-2.9M33.6M
 
 
 
 
 
Net Cash Flow - Operating Activities53.5M327.8M163.6M198.3M
 
 
 
 
 
 
InvestingIncrease In Investments-253.9M-120.6M-103.9M-85.8M
 
 
 
 
 
Decrease In Investments82.5M73.4M60.6M259.9M
 
 
 
 
 
Capital Expenditures-64.8M-70.9M-79.8M-117.5M
 
 
 
 
 
Net Cash Flow Investing-236.2M-118.1M-123.1M56.6M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-262.0K-61.4M-276.0K-159.8M
 
 
 
 
 
Net Proceeds Stock Sale55.0M8.0M17.7M45.2M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing117.3M126.9M99.3M105.0M
 
 
 
 
 
Other Uses - Financing63.1M144.9M110.9M243.2M
 
 
 
 
 
Net Cash Flow - Financing109.0M-71.4M5.9M-252.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.000.000.00--
 
Net Change In Cash-73.8M138.3M46.4M2.2M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account